TuisATYR • NASDAQ
add
aTyr Pharma Inc
Vorige sluiting
$2,98
Dagwisseling
$2,95 - $3,19
Jaarwisseling
$1,42 - $3,19
Markkapitalisasie
254,35 m USD
Gemiddelde volume
1,28 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | — | — |
Bedryfskoste | 3,34 m | 25,93% |
Netto inkomste | -17,26 m | -52,20% |
Netto winsgrens | — | — |
Wins per aandeel | -0,23 | -15,00% |
EBITDA | -17,96 m | -44,42% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 65,99 m | -35,39% |
Totale bates | 91,62 m | -26,75% |
Totale aanspreeklikheid | 26,48 m | -1,45% |
Totale ekwiteit | 65,14 m | — |
Uitstaande aandele | 83,94 m | — |
Prys om te bespreek | 3,47 | — |
Opbrengs op bates | -45,92% | — |
Opbrengs op kapitaal | -52,14% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -17,26 m | -52,20% |
Kontant van bedrywe | -13,16 m | -37,65% |
Kontant van beleggings | 17,95 m | 309,45% |
Kontant van finansiering | -105,00 k | -103,91% |
Netto kontantverandering | 4,68 m | 287,77% |
Beskikbare kontantvloei | -6,49 m | -12,66% |
Meer oor
aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.
The company's lead product candidate, ATYR1923, is a selective modulator of Neuropilin-2 that downregulates both the innate and adaptive immune responses in inflammatory disease states. aTyr is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung disease, a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need. ATYR1923 is currently being investigated in a clinical trial in pulmonary sarcoidosis patients.
The company was founded in 2005 and is headquartered in San Diego, California, and led by CEO Sanjay S. Shukla. Wikipedia
Gestig
01 Jan. 2005
Webwerf
Werknemers
58
